Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis.
Structure of the first sphingosine 1-phosphate receptor.
Self-management for people with long-term neurological conditions.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
Cognitive Impairment Has a Strong Relation to Nonsomatic Symptoms of Depression in Relapsing-Remitting Multiple Sclerosis.
Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
Effects of sleep and wake on oligodendrocytes and their precursors.
Central nervous system lymphoma associated with natalizumab.
Video game training enhances cognitive control in older adults.
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.
The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis-associated tremor.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
Multiple sclerosis and stress.
Innovation at RUSH
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
Heat shock protein 27 in multiple sclerosis relapses.
Added benefit of fampridine is not proven
Pages
« first
‹ previous
…
183
184
185
186
187
188
189
190
191
…
next ›
last »